Oparil S - Search Results

1

Blood Pressure Intervention and Control in SPRINT.

Cushman WC, Ringer RJ, Rodriguez CJ, Evans GW, Bates JT, Cutler JA, Hawfield A, Kitzman DW, Nasrallah IM, Oparil S, Nord J, Papademetriou V, Servilla K, Van Buren P, Whelton PK, Whittle J, Wright JT Jr; SPRINT Research Group. Cushman WC, et al. Among authors: oparil s. Hypertension. 2022 Sep;79(9):2071-2080. doi: 10.1161/HYPERTENSIONAHA.121.17233. Epub 2022 Jun 29. Hypertension. 2022. PMID: 35766041 Free article. Clinical Trial.

2

Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection.

Oparil S. Oparil S. Hypertension. 1999 Jan;33(1 Pt 2):170-6. doi: 10.1161/01.hyp.33.1.170. Hypertension. 1999. PMID: 9931100 Review.

3

Are there meaningful differences in blood pressure control with current antihypertensive agents?

Oparil S. Oparil S. Am J Hypertens. 2002 Jan;15(1 Pt 2):14S-21S. doi: 10.1016/s0895-7061(01)02272-5. Am J Hypertens. 2002. PMID: 11824870 Review.

4

Blood pressure and NaCl-sensitive hypertension are influenced by angiotensin-converting enzyme gene expression in transgenic mice.

Carlson SH, Oparil S, Chen YF, Wyss JM. Carlson SH, et al. Among authors: oparil s. Hypertension. 2002 Feb;39(2):214-8. doi: 10.1161/hy0202.104267. Hypertension. 2002. PMID: 11847186

5

Do angiotensin receptor antagonists have benefits beyond blood pressure lowering?

Oparil S. Oparil S. Curr Hypertens Rep. 2002 Jun;4(3):219-20. doi: 10.1007/s11906-002-0010-9. Curr Hypertens Rep. 2002. PMID: 12003704 Clinical Trial. No abstract available.

6

Alpha2A-adrenergic receptors mediate sympathoinhibitory responses to atrial natriuretic peptide in the mouse anterior hypothalamic nucleus.

Peng N, Chambless BD, Oparil S, Wyss JM. Peng N, et al. Among authors: oparil s. Hypertension. 2003 Mar;41(3):571-5. doi: 10.1161/01.HYP.0000056998.83031.22. Epub 2003 Feb 24. Hypertension. 2003. PMID: 12623961

7

Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse.

Wang D, Oparil S, Feng JA, Li P, Perry G, Chen LB, Dai M, John SW, Chen YF. Wang D, et al. Among authors: oparil s. Hypertension. 2003 Jul;42(1):88-95. doi: 10.1161/01.HYP.0000074905.22908.A6. Epub 2003 May 19. Hypertension. 2003. PMID: 12756220

8

Hormone replacement therapy and inflammation: interactions in cardiovascular disease.

Miller AP, Chen YF, Xing D, Feng W, Oparil S. Miller AP, et al. Among authors: oparil s. Hypertension. 2003 Oct;42(4):657-63. doi: 10.1161/01.HYP.0000085560.02979.0C. Epub 2003 Aug 11. Hypertension. 2003. PMID: 12913055

9

Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals.

Oparil S, Silfani TN, Walker JF. Oparil S, et al. Am J Hypertens. 2005 Feb;18(2 Pt 1):287-94. doi: 10.1016/j.amjhyper.2004.07.021. Am J Hypertens. 2005. PMID: 15752958 Review.

10

Gender and blood pressure.

Oparil S, Miller AP. Oparil S, et al. J Clin Hypertens (Greenwich). 2005 May;7(5):300-9. doi: 10.1111/j.1524-6175.2005.04087.x. J Clin Hypertens (Greenwich). 2005. PMID: 15886533 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

948 results

Search Page

Filters